These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS. BACK N; HIRAMOTO R; AMBRUS JL Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764 [No Abstract] [Full Text] [Related]
25. INACTIVATION OF ANTIPLASMIN AND COMPLEMENT C1 IN HUMAN PLASMA RENDERED FIBRINOLYTIC BY SYNTHETIC ORGANIC COMPOUNDS. VONKAULLA KN Thromb Diath Haemorrh; 1963 Nov; 10():151-63. PubMed ID: 14081277 [No Abstract] [Full Text] [Related]
26. [Evaluation of plasmin and trypsin by means of fibrinolytic and fibrinogenolytic methods]. CURT BOECKEL CR Sem Med; 1961 Oct; 119():1315-7. PubMed ID: 13882747 [No Abstract] [Full Text] [Related]
27. LYSIS OF THE EXPERIMENTAL RADIOACTIVE PULMONARY EMBOLUS INDUCED BY STREPTOKINASE AND SK-ACTIVATED PLASMIN. HUME M Thromb Diath Haemorrh; 1964 Apr; 11():99-107. PubMed ID: 14167120 [No Abstract] [Full Text] [Related]
28. [EXPERIENCE IN THE CLINICAL USE OF FIBRINOLYSIN]. PANCHENKO VM; ANDREENKO GV Ter Arkh; 1964 Jan; 36():43-51. PubMed ID: 14149444 [No Abstract] [Full Text] [Related]
29. [Characteristics of the clinical course and early treatment of pulmonary embolism with heparin and thrombolytic agents (fibrinolysin and streptokinase)]. BukhalovskiÄ IN; Morar' DI; Orlova VN; Skir SIa Ter Arkh; 1980; 52(3):118-20. PubMed ID: 6446169 [No Abstract] [Full Text] [Related]
30. The effect of fibrinolytic agents and anticoagulants on blood clot pulmonary emboli. CAHILL JM; BYRNE JJ; WHITE RL Surg Gynecol Obstet; 1963 Apr; 116():486-8. PubMed ID: 14017705 [No Abstract] [Full Text] [Related]
31. [PREVENTION OF EXPERIMENTAL THROMBOSIS IN SPLENECTOMIZED ANIMALS BY INTRAVENOUS ADMINISTRATION OF FIBRINOLYSIN WITH HEPARIN]. KUDRIASHOV BA; ANDREENKO GV; PASTOROVA VE Biull Eksp Biol Med; 1964 Sep; 58():39-41. PubMed ID: 14273457 [No Abstract] [Full Text] [Related]
32. Behavior in the circulation of the radioactive pulmonary embolus and its application to the study of fibrinolytic enzymes. HUME M; GLENN WW; GRILLO T Ann Surg; 1960 Apr; 151(4):507-16. PubMed ID: 14405346 [No Abstract] [Full Text] [Related]
33. TRANSPLANTABLE LUNG CANCER IN RATS. EFFECT OF TREATMENT. FARPOUR A; AGOSTINO D; CLIFFTON EE Arch Surg; 1964 Dec; 89():942-8. PubMed ID: 14208466 [No Abstract] [Full Text] [Related]
34. THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS. TSAPOGAS MJ Ann R Coll Surg Engl; 1964 May; 34(5):293-313. PubMed ID: 14145330 [No Abstract] [Full Text] [Related]
35. LETHALITY OF INTRAVASCULAR INJECTIONS OF SPLEEN AND LIVER CELLS. KAUFFMAN HM; CLARK RF; FISHER LM; HUME DM Ann Surg; 1964 Feb; 159(2):227-43. PubMed ID: 14119188 [No Abstract] [Full Text] [Related]
36. Fibrinolytic and Fibrino genolytic methods for estimating plasmin and trypsin. MULLERTZ S Acta Physiol Scand; 1952 Sep; 26(2-3):174-82. PubMed ID: 12985405 [No Abstract] [Full Text] [Related]
37. FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS. HECKER SP Calif Med; 1964 Jul; 101(1):23-9. PubMed ID: 14179527 [TBL] [Abstract][Full Text] [Related]
38. Thrombolytic therapy for the treatment of acute pulmonary embolism. Anderson DR; Levine MN CMAJ; 1992 Apr; 146(8):1317-24. PubMed ID: 1555162 [TBL] [Abstract][Full Text] [Related]
39. Variations in serum lipids with fibrinolytic and proteolytic activity in dogs and rabbits. BANG NU; CLIFFTON EE Am J Physiol; 1961 Feb; 200():323-6. PubMed ID: 13686573 [No Abstract] [Full Text] [Related]
40. [ON THE ACTION OF THROMBOLYTIC DRUGS]. PATEL J; CORMIER JM Mem Acad Chir (Paris); 1964 Jun; 90():628-30. PubMed ID: 14179177 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]